News tagged with oral tablet

NIH discontinues tenofovir vaginal gel in 'VOICE' HIV prevention study

A large-scale clinical trial evaluating whether daily use of an antiretroviral-containing oral tablet or vaginal gel can prevent HIV infection in women is being modified because an interim review found that the gel, an investigational ...

Medicine & Health / HIV & AIDS

created Nov 28, 2011 | popularity not rated yet | comments 0

Double duty: Anti-HIV topical gel also protects against herpes virus

HIV infection is commonly associated with other sexual infections, such as herpes simplex virus (HSV). Infection with HSV facilitates the risk of HIV infection and negatively impacts the clinical course of HIV disease. Therefore, ...

Medicine & Health / HIV & AIDS

created Oct 19, 2011 | popularity 3.7 / 5 (3) | comments 0

NIH modifies 'VOICE' HIV prevention study in women

A large-scale clinical trial evaluating whether daily use of an oral tablet or vaginal gel containing antiretroviral drugs can prevent HIV infection in women is being modified because an interim review found that the study ...

Medicine & Health / HIV & AIDS

created Sep 28, 2011 | popularity not rated yet | comments 0

Study comparing tenofovir gel and oral tablet finds gel provides more drug to tissue

In the first study to make head-to-head comparisons between tenofovir gel and oral tenofovir – two promising approaches for preventing HIV in women – researchers found that daily use of the vaginal gel achieved ...

Medicine & Health / HIV & AIDS

created Feb 28, 2011 | popularity not rated yet | comments 0

Clinical trial of antiretroviral-based HIV prevention strategies for women now under way

A new, large-scale clinical trial is examining whether antiretroviral medications normally used to treat HIV infection can also prevent HIV infection in women when applied as a vaginal gel or taken as oral tablets once daily.

Medicine & Health / HIV & AIDS

created Sep 16, 2009 | popularity not rated yet | comments 0

Diabetes drug shows promise against multiple sclerosis (w/Podcast)

A drug currently FDA-approved for use in diabetes shows some protective effects in the brains of patients with relapsing remitting multiple sclerosis, researchers at the University of Illinois at Chicago College of Medicine ...

Medicine & Health / Medications

created May 26, 2009 | popularity not rated yet | comments 0